NCT03898102View on ClinicalTrials.gov

Zinc Supplement in Regorafenib Treated mCRC Patient

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Regorafenib

regorafenib plus zinc gluconate

DIETARY_SUPPLEMENT

Zinc gluconate supplement

Zinc gluconate supplement

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03898102 - Zinc Supplement in Regorafenib Treated mCRC Patient | Biotech Hunter | Biotech Hunter